Literature DB >> 26041965

Encephalopathy in Wilson disease: copper toxicity or liver failure?

Peter Ferenci1, Tomasz Litwin2, Joanna Seniow2, Anna Czlonkowska3.   

Abstract

Hepatic encephalopathy (HE) is a complex syndrome of neurological and psychiatric signs and symptoms that is caused by portosystemic venous shunting with or without liver disease irrespective of its etiology. The most common presentation of Wilson disease (WD) is liver disease and is frequently associated with a wide spectrum of neurological and psychiatric symptoms. The genetic defect in WD leads to copper accumulation in the liver and later in other organs including the brain. In a patient presenting with Wilsonian cirrhosis neuropsychiatric symptoms may be caused either by the metabolic consequences of liver failure or by copper toxicity. Thus, in clinical practice a precise diagnosis is a great challenge. Contrary to HE in neurological WD consciousness, is very rarely disturbed and pyramidal signs, myoclonus dominate. Asterixis and many other clinical symptoms may be present in both disease conditions and are quite similar. However details of neurological assessment as well as additional examinations could help in differential diagnosis.

Entities:  

Keywords:  AHD, acquired hepatocerebral-degeneration; Cho, choline; EEG, electroencephalography; Glx, glutamine and glutamate; HE, hepatic encephalopathy; MHE, minimal hepatic encephalopathy; MI, myoinositol; MRI, magnetic resonance imaging; MRS, magnet resonance spectroscopy; NAA, N-acetyl-aspartate; WD, Wilson disease; Wilson disease; ammonia; copper; hepatic encephalopathy

Year:  2014        PMID: 26041965      PMCID: PMC4442862          DOI: 10.1016/j.jceh.2014.09.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  47 in total

1.  Wilson's disease. Clinical and laboratory maniestations in 40 patients.

Authors:  G T Strickland; M L Leu
Journal:  Medicine (Baltimore)       Date:  1975-03       Impact factor: 1.889

Review 2.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  Mania in a patient with Wilson's disease awaiting liver transplant.

Authors:  Sunny T Varghese; Dinesh Narayanan; Deepa Dinesh
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

4.  High prevalence of sleep disturbance in cirrhosis.

Authors:  J Córdoba; J Cabrera; L Lataif; P Penev; P Zee; A T Blei
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

5.  Wilson disease in septuagenarian siblings: Raising the bar for diagnosis.

Authors:  Aftab Ala; Jimo Borjigin; Arnold Rochwarger; Michael Schilsky
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease.

Authors:  Joanna Seniów; Thomas Bak; Jolanta Gajda; Renata Poniatowska; Anna Czlonkowska
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

8.  Neuropsychiatric aspects of treated Wilson's disease.

Authors:  Marina Svetel; Aleksandra Potrebić; Tanja Pekmezović; Aleksandra Tomić; Nikola Kresojević; Rada Jesić; Natasa Dragasević; Vladimir S Kostić
Journal:  Parkinsonism Relat Disord       Date:  2009-06-25       Impact factor: 4.891

Review 9.  Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.

Authors:  Christopher Randolph; Robin Hilsabeck; Ainobu Kato; Parampreet Kharbanda; Yu-Yuan Li; Daniela Mapelli; Lisa D Ravdin; Manuel Romero-Gomez; Andrea Stracciari; Karin Weissenborn
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

10.  Resolved Psychosis after Liver Transplantation in a Patient with Wilson's Disease.

Authors:  Orazio Sorbello; Daniela Riccio; Margherita Sini; Mauro Carta; Luigi Demelia
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-12-30
View more
  6 in total

1.  Hepatobiliary Quiz (Answers)-14 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-06-27

2.  Ligand-Capped CdTe Quantum Dots as a Fluorescent Nanosensor for Detection of Copper Ions in Environmental Water Sample.

Authors:  Hamideh Elmizadeh; Majid Soleimani; Farnoush Faridbod; Ghasem Rezanejade Bardajee
Journal:  J Fluoresc       Date:  2017-09-21       Impact factor: 2.217

Review 3.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

Review 4.  [Diagnostics of Wilson's disease].

Authors:  W Hermann; D Huster
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

5.  Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.

Authors:  Ali Calderon-Aparicio; Mary Strasberg-Rieber; Manuel Rieber
Journal:  Oncotarget       Date:  2015-10-06

6.  Hepatic encephalopathy.

Authors:  Peter Ferenci
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.